Robert Mauch Sells 5,096 Shares of Cencora (NYSE:COR) Stock

Cencora, Inc. (NYSE:COR) CEO Robert Mauch sold 5,096 shares of the business’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $366.64, for a total value of $1,868,397.44. Following the transaction, the chief executive officer owned 65,746 shares of the company’s stock, valued at approximately $24,105,113.44. The trade was a 7.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cencora Stock Performance

NYSE:COR opened at $362.05 on Friday. The stock has a market cap of $70.19 billion, a P/E ratio of 37.25, a PEG ratio of 1.56 and a beta of 0.63. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 3.64. The business’s 50-day moving average price is $326.44 and its two-hundred day moving average price is $304.06. Cencora, Inc. has a twelve month low of $223.92 and a twelve month high of $369.00.

Cencora (NYSE:COR) last posted its quarterly earnings data on Wednesday, November 5th. The company reported $3.84 earnings per share for the quarter, topping the consensus estimate of $3.79 by $0.05. Cencora had a net margin of 0.60% and a return on equity of 267.36%. The company had revenue of $83.73 billion for the quarter, compared to analysts’ expectations of $83.36 billion. During the same period in the prior year, the business earned $3.34 earnings per share. Cencora’s revenue for the quarter was up 5.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. As a group, equities analysts predict that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be issued a dividend of $0.60 per share. The ex-dividend date of this dividend is Friday, November 14th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. This is an increase from Cencora’s previous quarterly dividend of $0.55. Cencora’s payout ratio is presently 30.19%.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. UBS Group increased their target price on Cencora from $380.00 to $415.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Robert W. Baird upped their price objective on Cencora from $355.00 to $395.00 and gave the stock an “outperform” rating in a report on Thursday, November 6th. Mizuho raised their price objective on Cencora from $340.00 to $380.00 and gave the company an “outperform” rating in a report on Thursday, November 6th. Wells Fargo & Company upped their target price on Cencora from $354.00 to $405.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 11th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Cencora from $344.00 to $417.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 11th. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Cencora has an average rating of “Moderate Buy” and a consensus price target of $371.09.

Institutional Investors Weigh In On Cencora

Several institutional investors have recently bought and sold shares of COR. Atlantic Edge Private Wealth Management LLC lifted its position in Cencora by 70.0% in the second quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock valued at $25,000 after purchasing an additional 35 shares during the last quarter. Costello Asset Management INC purchased a new position in shares of Cencora in the first quarter worth $28,000. IAG Wealth Partners LLC purchased a new position in shares of Cencora in the third quarter worth $30,000. Vermillion & White Wealth Management Group LLC raised its holdings in Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after buying an additional 43 shares during the last quarter. Finally, Cloud Capital Management LLC purchased a new stake in Cencora during the 3rd quarter valued at $31,000. 97.52% of the stock is currently owned by hedge funds and other institutional investors.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.